Measurement of CYP450 Enzymes Activity of Bosentan in HepaRG Cell |
Han, Kyoung-Moon
(Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Jung, Jung-A (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Sin, Ji-Soon (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Cha, Hye-Jin (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Bae, Young-Ji (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Hyun-Uk (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kim, Young-Hoon (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Seong, Won-Keun (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) Kang, Hoil (Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) |
1 | Turpeinen, M., Tolonen, A., Chesne, C., Guillouzo, A., Uusitalo, J. and Pelkonen, O. : Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicol. In Vitro 23, 748 (2009). DOI ScienceOn |
2 | Lubberstedt, M., Muller-Vieira, U., Mayer, M., Biemel, K. M., Knospel, F., Knobeloch, D., Nussler, A. K., Gerlach, J. C. and Zeilinger, K. : HepaRG human hepatic cell line utililty as a surrogate for primary human Hepatocytes in drug metabolism assessment in vitro. J. Pharmacol. Toxicol. Methods 63, 59 (2011). DOI ScienceOn |
3 | Bowen, W. P., Carey, J. E., Miah, A., McMurray, H. F., Munday, P. W., James, R. S., Coleman, R. A. and Brown, A. M. : Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptasepolymerase chain reaction. Drug. Metab. Dispos. 28, 781 (2000). |
4 | Kanebratt, K. P. and Andersson, T. B. : Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug. Metab. Dispos. 36, 1444 (2008). DOI ScienceOn |
5 | Tolonen, A., Petsalo, A., Turpeinen, M., Uusitalo, J. and Pelkonen, O. : In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies. J. Mass Spectrom. 42, 960 (2007). DOI ScienceOn |
6 | Li, X., Chen, X., Li, Q., Wang, L. and Zhong, D. : Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 852, 128 (2007). DOI ScienceOn |
7 | Wrishko, R. E., Dingemanse, J., Yu, A., Darstein, C., Phillips, D. L. and Mitchell, M. I. : Pharmacokinetic interaction between tadalafil and Bosentan in healthy male subjects. J. Clin. Pharmacol. 48, 610 (2008). DOI |
8 | Kenworthy, K. E., Bloomer, J. C., Clarke, S. E. and Houston, J. B. : CYP3A4 drug interactions: correlation of 10 in vitro probes substrates. Br. J. Clin. Pharmacol. 48, 716 (1999). |
9 | Fahmi, O. A., Kish, M., Boldt, S. and Obach, R. S. : Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug. Metab. Dispos. 38, 1605 (2010). DOI ScienceOn |
10 | Yuan, R., Madani, S., Wei, X. X., Reynolds, K. and Huang, S. M. : Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug. Metab. Dispos. 30, 1311 (2002). DOI ScienceOn |
11 | McGinnity, D. F., Zhang, G., Kenny, J. R., Hamilton, G. A., Otmani, S., Stams, K. R., Haney, S., Brassil, P., Stresser, D. M. and Riley, R. J. : Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: Human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells. Drug. Metab. Dispos. 37, 1259 (2009). DOI ScienceOn |
12 | Fahmi, O. A. and Ripp, S. L. : Evaluation of models for prediction drug-drug interactions due to induction. Expert. Opin. Drug. Metab. Toxicol. 6, 1399 (2010). DOI ScienceOn |
13 | Drug Interaction Studies - Study design, data analysis, implications for dosing, and labeling recommendations, guidance for industry, FDA, Silver Spring, 2-75 (2012). |
14 | Balimane, P. V., Han, Y. H. and Chong, S. : Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical. AAPS J. 10, 391 (2008). DOI |
15 | Hewitt, N. J., Lecluyse, E. L. and Ferguson, S. S. : Induction of hepatic cytochrome P450 enzymes: Methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica. 37, 1196 (2007). DOI ScienceOn |
16 | Rodriguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V. and Gomez-Lechon, M. J. : Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanism that determine lower expression in cultured cells. Xenobiotica. 32, 505 (2002). DOI |
17 | Zhang, L., Zhang Y., Zhao, P. and Huang, S. M. : Prediction drug-drug interactions: An FDA perspective. AAPS J. 11, 2 (2009). |
18 | Guideline on the investigation of drug interactions, European Medicines Agency, 4-38 (2010). |
19 | Antherieu, S., Chesne, C., Li, R., Camus, S., Lahoz, A., Picazo, L., Turpeinen, M., Tolonen, A., Uusitalo, J., Guguen-Guillouzo, C. and Guillouzo, A. : Stable expression, activity and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug. Metab. Dispos. 38, 516 (2010). DOI ScienceOn |
20 | Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F. and Guguen-Guillouzo, C. : The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168, 66 (2007). DOI ScienceOn |
21 | Brandon, E. F., Raap, C. D., Meijerman, I., Beijnen, J. H. and Schellens, J. H. : An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 189, 233 (2003). DOI ScienceOn |